Zacks Investment Management Regeneron Pharmaceuticals, Inc. Transaction History

Zacks Investment Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$700.03 - $830.35 $254,810 - $302,247	364 New	364 $261,000
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $12,248 - $14,885	-18 Reduced 4.34%	397 $326,000
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $99,530 - $108,060	-141 Reduced 25.36%	415 $299,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $31,568 - $39,837	-55 Reduced 9.0%	556 $383,000
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $7.26 Million - $9.78 Million	-13,232 Reduced 95.59%	611 $361,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $654,036 - $767,574	1,099 Added 8.62%	13,843 $9.67 Million
Q4 2021 Feb 15, 2022	BUY	$543.48 - $670.97 $523,914 - $646,815	964 Added 8.18%	12,744 $8.05 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $493,091 - $584,944	859 Added 7.87%	11,780 $7.13 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $381,076 - $450,183	806 Added 7.97%	10,921 $6.1 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $4.52 Million - $5.55 Million	10,115 New	10,115 $4.79 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $199,477 - $239,405	-594 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $208,577 - $242,654	594 New	594 $240,000

1,497

82.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.